Evaluation of a novel antiosteolytic agent: potential in breast-to-bone metastasis and mechanism of action [ 2009 - 2011 ]

Research Grant

Researchers: Dr Mark Waltham (Principal investigator)

Brief description In breast cancer the spread of cancer (metastasis) to bone occurs frequently and causes significant problems including pain, fracture, immobility and paralysis. We have recently discovered that a drug, widely used in Japan and Korea for skin disorders, inhibits breast cancer growth in bone using animal model systems of this disease. This is a very exciting and novel finding. We will further investigate the potential of this drug and identify precisely how it works at the molecular level.

Funding Amount $AUD 352,583.00

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant